发布求助
文献互助 智能选刊 最新文献

The Brown University Psychopharmacology Update最新文献

筛选
英文 中文
Tirzepatide reduces sleep events in patients with sleep apnea and obesity 替扎帕肽可减少睡眠呼吸暂停和肥胖症患者的睡眠事件
The Brown University Psychopharmacology Update Pub Date : 2024-09-04 DOI: 10.1002/pu.31214
{"title":"Tirzepatide reduces sleep events in patients with sleep apnea and obesity","authors":"","doi":"10.1002/pu.31214","DOIUrl":"https://doi.org/10.1002/pu.31214","url":null,"abstract":"<p>Two Phase 3 trials have found that tirzepatide, a medication used to treat type 2 diabetes, reduced apnea events and body weight in patients with obstructive sleep apnea and obesity. Tirzepatide had comparable safety results to placebo in the two trials.</p>","PeriodicalId":22275,"journal":{"name":"The Brown University Psychopharmacology Update","volume":"35 10","pages":"4"},"PeriodicalIF":0.0,"publicationDate":"2024-09-04","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142137652","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Antidepressant discontinuation led to adverse symptoms one-third of the time 三分之一的患者在停用抗抑郁药后出现不良症状
The Brown University Psychopharmacology Update Pub Date : 2024-09-04 DOI: 10.1002/pu.31211
{"title":"Antidepressant discontinuation led to adverse symptoms one-third of the time","authors":"","doi":"10.1002/pu.31211","DOIUrl":"https://doi.org/10.1002/pu.31211","url":null,"abstract":"<p>A systematic review and meta-analysis encompassing 79 studies has found that around one-third of patients who discontinue antidepressant medication will experience adverse symptoms, but only around 1 in 30 will experience severe discontinuation symptoms. An analysis of individual antidepressants found that imipramine, desvenlafaxine, and venlafaxine were associated with the highest incidence of discontinuation symptoms. Results were published online June 5, 2024, in <i>Lancet Psychiatry</i>.</p>","PeriodicalId":22275,"journal":{"name":"The Brown University Psychopharmacology Update","volume":"35 10","pages":"1-6"},"PeriodicalIF":0.0,"publicationDate":"2024-09-04","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142137649","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Topiramate compares favorably to naltrexone for alcohol use disorder 托吡酯与纳曲酮相比，在治疗酒精使用障碍方面效果更佳
The Brown University Psychopharmacology Update Pub Date : 2024-09-04 DOI: 10.1002/pu.31213
{"title":"Topiramate compares favorably to naltrexone for alcohol use disorder","authors":"","doi":"10.1002/pu.31213","DOIUrl":"https://doi.org/10.1002/pu.31213","url":null,"abstract":"<p>A 12-week randomized trial involving 147 participants has found that topiramate was as effective as naltrexone in reducing drinking behaviors in patients with alcohol use disorder (AUD). A secondary analysis found no association between two gene poly­morphisms and patient response to the medication treatments.</p>","PeriodicalId":22275,"journal":{"name":"The Brown University Psychopharmacology Update","volume":"35 10","pages":"3"},"PeriodicalIF":0.0,"publicationDate":"2024-09-04","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142137651","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Some anti-psychotics associated with increased risk of pneumonia 某些抗精神病药物与肺炎风险增加有关
The Brown University Psychopharmacology Update Pub Date : 2024-09-04 DOI: 10.1002/pu.31216
{"title":"Some anti-psychotics associated with increased risk of pneumonia","authors":"","doi":"10.1002/pu.31216","DOIUrl":"https://doi.org/10.1002/pu.31216","url":null,"abstract":"","PeriodicalId":22275,"journal":{"name":"The Brown University Psychopharmacology Update","volume":"35 10","pages":"7"},"PeriodicalIF":0.0,"publicationDate":"2024-09-04","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142137709","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Use of SSRIs with anticoagulants can increase risk of bleeding 使用 SSRIs 和抗凝血剂会增加出血风险
The Brown University Psychopharmacology Update Pub Date : 2024-09-04 DOI: 10.1002/pu.31218
{"title":"Use of SSRIs with anticoagulants can increase risk of bleeding","authors":"","doi":"10.1002/pu.31218","DOIUrl":"https://doi.org/10.1002/pu.31218","url":null,"abstract":"","PeriodicalId":22275,"journal":{"name":"The Brown University Psychopharmacology Update","volume":"35 10","pages":"7-8"},"PeriodicalIF":0.0,"publicationDate":"2024-09-04","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142137776","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Approval 批准
The Brown University Psychopharmacology Update Pub Date : 2024-09-04 DOI: 10.1002/pu.31221
{"title":"Approval","authors":"","doi":"10.1002/pu.31221","DOIUrl":"https://doi.org/10.1002/pu.31221","url":null,"abstract":"","PeriodicalId":22275,"journal":{"name":"The Brown University Psychopharmacology Update","volume":"35 10","pages":"8"},"PeriodicalIF":0.0,"publicationDate":"2024-09-04","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142137711","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Anti-psychotic use in dementia patients linked to risk of numerous illnesses 痴呆症患者服用抗精神病药与多种疾病风险有关
The Brown University Psychopharmacology Update Pub Date : 2024-09-04 DOI: 10.1002/pu.31219
{"title":"Anti-psychotic use in dementia patients linked to risk of numerous illnesses","authors":"","doi":"10.1002/pu.31219","DOIUrl":"https://doi.org/10.1002/pu.31219","url":null,"abstract":"","PeriodicalId":22275,"journal":{"name":"The Brown University Psychopharmacology Update","volume":"35 10","pages":"8"},"PeriodicalIF":0.0,"publicationDate":"2024-09-04","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142137775","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Your Medication Information 您的用药信息
The Brown University Psychopharmacology Update Pub Date : 2024-08-02 DOI: 10.1002/pu.31209
{"title":"Your Medication Information","authors":"","doi":"10.1002/pu.31209","DOIUrl":"https://doi.org/10.1002/pu.31209","url":null,"abstract":"<p>Aripiprazole (generic) — Abilify (brand)</p>","PeriodicalId":22275,"journal":{"name":"The Brown University Psychopharmacology Update","volume":"35 9","pages":"9-10"},"PeriodicalIF":0.0,"publicationDate":"2024-08-02","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"141966615","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Lipid-modifying statins, fibrates reduce mortality in schizophrenia patients 调节血脂的他汀类药物和纤维酸盐可降低精神分裂症患者的死亡率
The Brown University Psychopharmacology Update Pub Date : 2024-08-02 DOI: 10.1002/pu.31199
{"title":"Lipid-modifying statins, fibrates reduce mortality in schizophrenia patients","authors":"","doi":"10.1002/pu.31199","DOIUrl":"https://doi.org/10.1002/pu.31199","url":null,"abstract":"<p>A nationwide cohort study conducted in Taiwan has found that lipid-modifying agents, particularly statins and fibrates, reduce mortality risk in patients with schizophrenia. The reduced risk was apparent for both all-cause and natural-cause mortality, the investigators reported. Study results were published online May 16, 2024, in <i>The British Journal of Psychiatry</i>.</p>","PeriodicalId":22275,"journal":{"name":"The Brown University Psychopharmacology Update","volume":"35 9","pages":"1-6"},"PeriodicalIF":0.0,"publicationDate":"2024-08-02","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"141966621","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Many women not heeding warnings on valproic acid's risks in pregnancy 许多妇女没有注意到关于丙戊酸在怀孕期间的风险警告
The Brown University Psychopharmacology Update Pub Date : 2024-08-02 DOI: 10.1002/pu.31198
{"title":"Many women not heeding warnings on valproic acid's risks in pregnancy","authors":"","doi":"10.1002/pu.31198","DOIUrl":"https://doi.org/10.1002/pu.31198","url":null,"abstract":"<p>Despite intensified warnings from regulators about fetal risk associated with the use of valproic acid during pregnancy, pregnancy incidence rates in women receiving valproic acid have remained largely unchanged, results of a cohort study suggest. Use of contraception in this population has also remained low overall, the investigators reported. Study results were published May 22, 2024, in <i>JAMA Network Open</i>.</p>","PeriodicalId":22275,"journal":{"name":"The Brown University Psychopharmacology Update","volume":"35 9","pages":"1-5"},"PeriodicalIF":0.0,"publicationDate":"2024-08-02","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"141966620","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
首页 上一页
0
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
提示
您的信息不完整，为了账户安全，请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
现在去查看 取消
×
提示
确定
请完成安全验证×
相关产品
×
本文献相关产品
联系我们：info@booksci.cn Book学术提供免费学术资源搜索服务，方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。 Copyright © 2023 布克学术 All rights reserved.
京ICP备2023020795号-1
ghs 京公网安备 11010802042870号
Book学术文献互助
Book学术文献互助群
群 号：481959085
Book学术官方微信